Page last updated: 2024-09-04

naproxen and Dyspepsia

naproxen has been researched along with Dyspepsia in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's7 (63.64)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amazonas, RB; Bocchi de Oliveira, MF; Ecclissato, C; Macêdo, EA; Pott Júnior, H; Scheinberg, M1
Blumenthal, R; Cundy, KC; Ho, J; Lal, R; Luo, W; Sukbuntherng, J; Vicente, V1
Cryer, BL; Fort, JG; Hochberg, MC; Hwang, C; Sostek, MB; Svensson, O1
Akyürek, C; Celik, C; Celik, JB; Reisli, R; Sarkilar, G; Tuncer, S1
Burke, TA; Goldstein, JL; Henderson, SC; Palmer, R; von Allmen, H; Zhao, SZ1
Goldstein, JL; Mayne, TJ; Rabeneck, L; Rublee, DA; Vu, A1
Chan, AO; Chu, KM; Hu, WH; Hui, WM; Lai, KC; Lam, SK; Wong, BC; Wong, J; Wong, WM1
Aisenberg, J; Benson, AA; Bodian, CA; Cohen, LB; Desai, JC; Goo, T; Miller, KM; Sanyal, SM1
Agrawal, NM; Bensen, WG; Burke, TA; Geis, GS; Makuch, RW; Maurath, CJ; Zabinski, RA; Zhao, SZ1
Bevirt, T; Makarowski, W; Recker, DP; Zhao, WW1
Andreasen, F; Egsmose, C; Gøtzsche, PC; Lund, B1

Trials

8 trial(s) available for naproxen and Dyspepsia

ArticleYear
Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms.
    Drug design, development and therapy, 2018, Volume: 12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Esomeprazole; Female; Humans; Male; Middle Aged; Naproxen; Osteoporosis; Pain; Pain Management; Pantoprazole; Sulfonamides; Tablets

2018
A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Annals of medicine, 2011, Volume: 43, Issue:8

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Combinations; Dyspepsia; Esomeprazole; Female; Gastrointestinal Tract; Heartburn; Humans; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Pyrazoles; Sulfonamides; Tablets, Enteric-Coated; Treatment Outcome

2011
A comparative study of the effect of rofecoxib (a COX 2 inhibitor) and naproxen sodium on analgesic requirements after abdominal hysterectomy.
    Archives of gynecology and obstetrics, 2003, Volume: 268, Issue:4

    Topics: Adult; Analgesia; Cyclooxygenase Inhibitors; Dyspepsia; Female; Gastrointestinal Diseases; Heartburn; Humans; Hysterectomy; Lactones; Middle Aged; Morphine; Naproxen; Placebos; Postoperative Nausea and Vomiting; Premedication; Sulfones

2003
Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    The American journal of gastroenterology, 2005, Volume: 100, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Dyspepsia; Female; Humans; Ibuprofen; Isoxazoles; Male; Middle Aged; Naproxen; Osteoarthritis; Pain Measurement; Patient Satisfaction; Placebos; Quality of Life; Sulfonamides; Treatment Outcome; Upper Gastrointestinal Tract

2005
Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    The American journal of medicine, 2005, Volume: 118, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Middle Aged; Naproxen; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Pyrazoles; Recurrence; Risk Factors; Sulfonamides; Treatment Outcome

2005
Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:8

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Dyspepsia; Female; Gastroscopy; Helicobacter pylori; Humans; Male; Middle Aged; Naproxen; Omeprazole; Pilot Projects; Proton Pump Inhibitors; Reference Values; Stomach Ulcer; Treatment Outcome

2008
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    The Journal of rheumatology, 2000, Volume: 27, Issue:8

    Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Digestive System; Double-Blind Method; Dyspepsia; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Naproxen; Nausea; Osteoarthritis; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Risk Factors; Sulfonamides; Time Factors; Treatment Outcome

2000
Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen.
    Osteoarthritis and cartilage, 2002, Volume: 10, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Constipation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Administration Schedule; Dyspepsia; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Middle Aged; Naproxen; Osteoarthritis, Hip; Prostaglandin-Endoperoxide Synthases; Sulfonamides

2002

Other Studies

3 other study(ies) available for naproxen and Dyspepsia

ArticleYear
Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine.
    British journal of clinical pharmacology, 2010, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Biological Transport; Carbamates; Cimetidine; Constipation; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Dyspepsia; Fatigue; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Naproxen; Prodrugs; Young Adult

2010
Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:12

    Topics: Abdominal Pain; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Dyspepsia; Female; Humans; Ibuprofen; Incidence; Insurance Claim Reporting; Male; Middle Aged; Naproxen; Nausea; Outpatients; Poisson Distribution; Proportional Hazards Models; Pyrazoles; Risk Factors; Sulfonamides; United States; Vomiting

2003
Steady state pharmacokinetics of naproxen in elderly rheumatics compared with young volunteers.
    Scandinavian journal of rheumatology, 1988, Volume: 17, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Diuretics; Dyspepsia; Female; Humans; Male; Naproxen; Osmolar Concentration; Rheumatic Diseases; Serum Albumin

1988